Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression.
J Immunother Cancer. 2022 Sep;10(9):e004859. doi: 10.1136/jitc-2022-004859.
J Immunother Cancer. 2022.
PMID: 36096532
Free PMC article.
Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells.
Yehudai-Resheff S, Attias-Turgeman S, Sabbah R, Gabay T, Musallam R, Fridman-Dror A, Zuckerman T.
Yehudai-Resheff S, et al. Among authors: fridman dror a.
Int J Cancer. 2019 May 1;144(9):2279-2289. doi: 10.1002/ijc.32063. Epub 2018 Dec 31.
Int J Cancer. 2019.
PMID: 30548585
Free article.
Item in Clipboard
Donor cell leukemia: reappearance of gene mutations in donor cells - more than an incidental phenomenon?
Shahar Gabay T, Chapal-Ilani N, Moskovitz Y, Biezuner T, Oron B, Brilon Y, Fridman-Dror A, Sabah R, Balicer R, Tanay A, Mendelson-Cohen N, Dann EJ, Fineman R, Kaushansky N, Yehudai-Reshef S, Zuckerman T, Shlush LI.
Shahar Gabay T, et al. Among authors: fridman dror a.
Haematologica. 2020 Dec 1;105(12):2861-2863. doi: 10.3324/haematol.2019.242347.
Haematologica. 2020.
PMID: 33256388
Free PMC article.
No abstract available.
Item in Clipboard
Item in Clipboard
Cite
Cite